A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ALLN / N-acetyl-Leu-Leu-norleucinal

[Related PubMed/MEDLINE]
Total Number of Papers: 28
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ALLN  (>> Co-occurring Abbreviation)
Long Form:   N-acetyl-Leu-Leu-norleucinal
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Effects of calpain inhibitor on the apoptosis of hepatic stellate cells induced by calcium ionophore A23187. ER, ERS, HSCs
2018 Ischemia-reperfusion induces death receptor-independent necroptosis via calpain-STAT3 activation in a lung transplant setting. CIT, I/R, MLKL, Nec-1, PGD, RIPK1, RN, STAT3
2017 Hippocampal calpain is required for the consolidation and reconsolidation but not extinction of contextual fear memory. ---
2014 UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer. ---
2013 ALLN hinders HCT116 tumor growth through Bax-dependent apoptosis. ---
2008 Down-regulation of brain-pancreas relative protein in diabetic rats and by high glucose in PC12 cells: prevention by calpain inhibitors. BPRP
2005 Inhibitors of ubiquitin-dependent proteolysis can delay programmed cell death of adult intersegmental muscles in the moth Manduca sexta. DIM-A4, ISMs, PCD
2005 Involvement of calpain in melanogenesis of mouse B16 melanoma cells. a-MSH, CS
2005 Novel glycosaminoglycan mimetic (RGTA, RGD120) contributes to enhance skeletal muscle satellite cell fusion by increasing intracellular Ca2+ and calpain activity. GAG, RGTA
10  2004 Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32. GSK-3beta, WT
11  2003 Effect of cold preservation on intracellular calcium concentration and calpain activity in rat sinusoidal endothelial cells. ALLM, BAPTA-AM, EC, IPRL, SEC
12  2003 Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal kinase and p38. AP-1, DCI, Egr-1, IkappaB, LPS, NF-kappaB, TF, TPCK
13  2002 2',5'-Dihydroxychalcone down-regulates endothelial connexin43 gap junctions and affects MAP kinase activation. Cx43, FCS, FRAP, HUVEC, MAP
14  2002 Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. ABC
15  2002 Regulation of transformed state by calpastatin via PKCepsilon in NIH3T3 mouse fibroblasts. PKC
16  2001 Peptide transport by the multidrug resistance protein MRP1. MRP
17  2000 Characterization of peroxisomal 3-hydroxy-3-methylglutaryl coenzyme A reductase in UT2 cells: sterol biosynthesis, phosphorylation, degradation, and statin inhibition. ER, HMG-CoA
18  2000 Differential expression of cell-cell adhesion proteins and cyclin D in MEK1-transdifferentiated MDCK cells. C7caMEK1, caMEK1, MDCK
19  2000 Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. ---
20  1999 Regulation of BRCA1 by protein degradation. ---
21  1999 The role of beta-catenin stability in mutant PS1-associated apoptosis. FAD, PS1, PS2
22  1999 Ubiquitin-proteasome system is involved in induction of LFA-1/ICAM-1-dependent adhesion of HL-60 cells. LC, ZLL
23  1998 Agonist-induced down-regulation of type 1 and type 3 inositol 1,4,5-trisphosphate receptors in A7r5 and DDT1 MF-2 smooth muscle cells. InsP3R-1, InsP3R3
24  1998 Identification of tropoelastin as a ligand for the 65-kD FK506-binding protein, FKBP65, in the secretory pathway. BFA
25  1998 Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma. ALLM, MMP, SCC, TNF-alpha
26  1997 Cysteine proteinases are responsible for characteristic transketolase alterations in Alzheimer fibroblasts. AD, TK
27  1997 Effects of an inhibitor of cathepsin L on bone resorption in thyroparathyroidectomized and ovariectomized rats. i.p, pQCT, sCT
28  1997 Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. FC, LDL, SREs